Should atrial fibrillation patients with only 1 nongender-related CHA2DS2-VASc risk factor be anticoagulated?

Stroke

Volumn 47, Issue 7, 2016, Pages 1831-1836

  Fauchier, Laurent ^a   Clementy, Nicolas ^a   Bisson, Arnaud ^a   Ivanes, Fabrice ^a   Angoulvant, Denis ^a   Babuty, Dominique ^a   Lip, Gregory Y H ^b,c  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

atrial fibrillation; embolism; risk factor; stroke

Indexed keywords

ANTICOAGULANT AGENT;

AGE; AGED; ATRIAL FIBRILLATION; COMORBIDITY; COMPLICATION; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STROKE; THROMBOPHILIA; UNNECESSARY PROCEDURE; VASCULAR DISEASES;

AGE FACTORS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; COMORBIDITY; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; THROMBOPHILIA; UNNECESSARY PROCEDURES; VASCULAR DISEASES;

EID: 84970015745     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.013253     Document Type: Article

References (15)

1. Hart RG, Pearce LA, Aguilar MI, Meta-Analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007 146 857 867
2. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010 137 263 272. doi: 10.1378/chest.09-1584.
3. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, ESC Committee for Practice Guidelines (CPG) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012 33 2719 2747. doi: 10.1093/eurheartj/ehs253.
4. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014 64 e1 76. doi: 10.1016/j.jacc.2014.03.022.
5. National Clinical Guideline Centre (UK). Atrial Fibrillation: The Management of Atrial Fibrillation [Internet] 2014 London, United Kingdom National Institute for Health and Care Excellence (UK). http://www.ncbi.nlm.nih.gov/books/NBK248059/. Accessed April 14, 2016.
6. Taillandier S, Brunet Bernard A, Lallemand B, Simeon E, Pericart L, Clementy N, Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure. Am J Cardiol 2014 113 1189 1195. doi: 10.1016/j.amjcard.2013.12.024.
7. Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol 2013 61 2079 2087. doi: 10.1016/j.jacc.2013.02.035.
8. Philippart R, Brunet-Bernard A, Clementy N, Bourguignon T, Mirza A, Babuty D, Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. Eur Heart J 2015 36 1822 1830. doi: 10.1093/eurheartj/ehv163.
9. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006 151 713 719. doi: 10.1016/j.ahj.2005.04.017.
10. Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, European Heart Rhythm Association Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb Haemost 2011 106 997 1011. doi: 10.1160/TH11-10-0690.
11. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Academic Research Consortium Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007 115 2344 2351. doi: 10.1161/CIRCULATIONAHA.106.685313.
12. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009 151 297 305
13. Connolly SJ, Eikelboom JW, Ng J, Hirsh J, Yusuf S, Pogue J, ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Steering Committee and Investigators Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Ann Intern Med 2011 155 579 586. doi: 10.7326/0003-4819-155-9-201111010-00004.
14. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 141 e531S 575S
15. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006 27 1979 2030. doi: 10.1093/eurheartj/ehl176.